Crown Bioscience Appoints Guy Sheets as Senior Vice President, Commercial

SAN DIEGO—November 2, 2026 — Crown Bioscience, a global contract research organization (CRO) specializing in oncology drug discovery and development, today announced the appointment of Guy Sheets as Senior Vice President, Commercial.

Guy will lead Crown Bioscience’s global commercial strategy, with responsibility for driving growth, expanding market presence, and strengthening client partnerships. He will work closely with scientific and operational leaders to connect the company’s preclinical and translational research capabilities with the evolving needs of biotechnology and pharmaceutical clients.

Guy brings more than 30 years of commercial leadership experience across the pharmaceutical, biotechnology, and life sciences industries. Most recently, he served as Vice President, Head of Global Business Development at QPS Holdings, leading commercial organizations supporting preclinical and clinical contract research services. He previously held senior leadership positions at CenExel Clinical Research, SGS Health Sciences, and Lonza, with earlier roles at Thermo Fisher Scientific and SCHOTT.

“Guy brings extensive experience in research services and a strong track record of building high-performing global commercial teams, and a deep commitment to developing lasting client partnership,” said John Gu, Chief Executive Officer of Crown Bioscience. “His leadership will help us strengthen our global commercial organization, deepen customer engagement and better align our scientific expertise with evolving clients’ needs as we enter our next phase of growth.”

Media Inquiries:
Crown Bioscience
Sarah Martin-Tyrrell
pr@crownbio.com